ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Feb 25, 2025
Public Storage Impacted by California Wildfires
Image Source: Public Storage. Looking to 2025, Public Storage expects revenue growth in the range of -1.3%-0.8%, with net operating income growth in the range of -2.9%-0.2%. On a consolidated basis, non-same store net operating income is expected to be between $444-$464 million, while ancillary net operating income is expected to be between $198-$203 million. Funds for development openings is targeted at $370 million with maintenance of real estate facilities and energy efficiencies expected at $150 million and $50 million, respectively. Core FFO per share is expected to be between $16.35-$17.00 (below the consensus forecast of $17.18), implying growth of -1.9%-2% on a year-over-year basis. The wildfires in Southern California in early 2025 will negatively impact core FFO for 2025 by $0.23 on both the low-end and high-end of its guidance range.
Feb 25, 2025
Domino’s Remains a Key Idea in the Best Ideas Newsletter Portfolio
Image: Domino’s shares have advanced nicely since the beginning of 2023. For fiscal 2024, net cash provided by operating activities increased 5.8% on a year-over-year basis, while capital expenditures expanded 7.1%, resulting in free cash flow growth of 5.5%, to $512 million. The company experienced global net store growth of 775 for fiscal 2024, and we continue to like Domino’s future growth prospects. During the fourth quarter, the company repurchased a total of $112 million in stock, and as of December 29, had total remaining buyback authorization of $814.3 million. We like Domino’s long-term picture and include the firm as a holding in the Best Ideas Newsletter portfolio.
Feb 21, 2025
Booking Holdings' Revenue Accelerates in Fourth Quarter
Image Source: Booking Holdings. Booking Holdings is doing a great job returning cash to shareholders. The company declared a quarterly cash dividend of $9.60 per share, a 10% increase from its quarterly cash dividend of $8.75 per share in 2024. The company repurchased $1.1 billion of stock during the fourth quarter of 2024, and the firm has remaining buyback authorization of $7.7 billion. For the full year 2024, free cash flow was $7.9 billion, roughly 33.3% of sales. Cash and long-term investments were $16.7 billion at the end of the year, about in line with short- and long-term debt of $16.6 billion. We liked Booking Holdings’ accelerated performance in the fourth quarter of 2024 and remain huge fans of its free cash flow generating prowess.
Feb 21, 2025
Walmart’s Earnings Outlook Falls Short of Expectations
Image Source: Walmart. Walmart ended its fiscal year with cash and cash equivalents of $9.0 billion and total debt of $45.8 billion. Operating cash flow for fiscal 2025 was $36.4 billion, an increase of $0.7 billion from last year, while free cash flow remained robust at $12.7 billion. Looking to the first quarter of fiscal 2026, net sales are expected to increase 3%-4%, while adjusted operating income is expected to advance 0.5%-2%, with adjusted earnings per share targeted in the range of $0.57-$0.58, below the $0.65 consensus estimate. For all of fiscal 2026, net sales are anticipated to increase 3%-4%, with adjusted operating income expected to increase 3.5%-5.5%. Adjusted earnings per share is targeted in the range of $2.50-$2.60 for the full year (consensus was at $2.76), inclusive of a $0.05 headwind from currency. Shares yield 0.9%.
Feb 21, 2025
Dividend Increases/Decreases for the Week of February 21
Let's take a look at firms raising/lowering their dividends this week.
Feb 19, 2025
Albemarle Has Line of Sight to Breakeven Free Cash Flow in 2025
Image Source: Albemarle. Albemarle recorded full-year cash flow from operations of $702 million, which represented 60% of adjusted EBITDA, revealing good cash flow conversion. Management plans to further reduce 2025 capital expenditures by $100 million, to the range of $700-$800 million, down more than 50% on a year-over-year basis. Albemarle noted that it has a “line of sight to breakeven free cash flow in 2025,” which should alleviate some pressure on its stock.
Feb 19, 2025
Republic Services Remains a Cash Cow
Image Source: Republic Services. For the full year, Republic’s cash provided by operating activities was $3.94 billion, up 8.8% from last year. Adjusted free cash flow was $2.18 billion, an increase of 10% versus the prior year. The company returned $1.18 billion in cash to shareholders during 2024, consisting of $490 million of share repurchases and $687 million of dividends paid. Looking to 2025, Republic expects revenue in the range of $16.85-$16.95 billion and adjusted EBITDA in the range of $5.275-$5.325 billion. Adjusted diluted earnings per share is targeted in the range of $6.82-$6.90 for the year, while adjusted free cash flow is expected in the range of $2.32-$2.36 billion. We continue to like Republic Services as an idea in the newsletter portfolios.
Feb 14, 2025
Dividend Increases/Decreases for the Week of February 14
Let's take a look at firms raising/lowering their dividends this week.
Feb 13, 2025
Cisco Ups Fiscal 2025 Guidance Again
Image Source: Cisco. Looking to fiscal third quarter guidance, Cisco's revenue is expected to be between $13.9-$14.1 billion, and non-GAAP earnings per share to be between $0.90-$0.92. For all of fiscal 2025, management expects revenue in the range of $56-$56.5 billion (was $55.3-$56.3 billion) and non-GAAP earnings per share in the range of $3.68-$3.74 (was $3.60-$3.66 per share). We continue to like Cisco as a holding in both the Best Ideas Newsletter portfolio and Dividend Growth Newsletter portfolio. The high end of our fair value estimate range stands at $73 per share.
Feb 11, 2025
Vertex Pharma Is One of Our Favorite Biotechs
Image: Vertex Pharma has performed quite well since the beginning of 2023. Looking to 2025, Vertex expects total revenue of $11.75-$12 billion, which includes expectations for continued growth in its cystic fibrosis portfolio, “including the U.S. launch of ALYFTREK, as well as continued uptake of CASGEVY in multiple regions; and early contributions from the launch of JOURNAVX." Cash and total marketable securities as of the end of last year were $11.2 billion, compared to $13.7 billion at the end of 2023 due to the cash consideration paid to acquire Alpine and share buybacks. Vertex had no traditional debt. We continue to like Vertex Pharma as a holding in the Best Ideas Newsletter portfolio.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.